Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
 
Register now or login to post to this thread.

Bioprogress (BPRG)     

scorpion - 13 Aug 2003 13:54

Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.

Big Al - 13 Sep 2004 10:26 - 919 of 2372

A bit late to change the listing date.

Unfortunately news management in BPRG is garbage. Potential is there and I hope they haven't cocked that bit up!!!

;-)

Janus - 14 Sep 2004 07:16 - 920 of 2372

New patent granted


http://www.uk-wire.com/cgi-bin/articles/200409140700219176c.html

azhar - 14 Sep 2004 07:56 - 921 of 2372

Yipee yet another success. These RNS are never ending here

Janus - 14 Sep 2004 13:41 - 922 of 2372

Film specialist gets honeycomb capsule patent


14/09/2004 - BioProgress has had one of its pending patents granted in Europe, shoring up its intellectual property in the area of foamed films used for rapid delivery of drugs into the mouth.

The patent relates to a new type of capsule made from foamed film, whereby gas is blown into the film during production resulting in a film with a honeycombed structure. The voids in the film may be gas filled, empty or filled with other materials to produce specific taste-burst characteristics or to deliver active pharmaceutical ingredients (APIs).
The light honeycombed film structure results in capsules that dissolve rapidly, releasing the capsule contents into the mouth. The capsule wall film residue also dissolves quickly with a pleasant melt-in-the-mouth sensation that the company claims is more pleasant than rival technologies based on gelatine. These are chewy and remain in the mouth long after the capsule contents have been delivered, it says.

Quick-dissolving film strips are already being used in breath freshening product introductions from Warner Lambert and Wrigley's in the USA and Europe, and Boots in the UK, as well as vitamin products. BioProgress has designs on adapting this technology for the pharma sector, and earlier this year acquired the edible film business of Florida-based Aquafilm to boost its capabilities in this area.

BioProgress believes that the primary advantage of its foam-filled approach is that it supports the delivery of drugs requiring higher individual doses than is possible in a single square of dissolve-in-the-mouth film. This is simply because the physical film volume in a small square of conventional film is too small to accommodate a large dose of drug.

The patent also covers a double chamber capsule a technology that BioProgress is developing under the Septum banner with its conventional cellulose films than can be made from this foamed film. This will enable two separate actives to be released simultaneously in-the-mouth.

While still used in only a minority of oral medicines - with estimated annual sales $1.7 billion (1.5m) in 2002 - fast-melt delivery is experiencing 40 per cent growth a year as companies turn to it to differentiate their products in the marketplace. BioProgress also has another fast-melt technology, called Soluleaves,

Graham Hind, BioProgress chief executive, said that the company was making progress on building the capacity to work with foamed film capsules, with the preliminary machine design for their now completed.

http://www.inpharma.com/news/news-NG.asp?n=54695-film-specialist-gets>

nematode - 15 Sep 2004 09:41 - 923 of 2372

This baby is a beauty!!!

hlyeo98 - 16 Sep 2004 12:36 - 924 of 2372

Good patent news boosted coatings technology group BioProgress, after the one of its films for oral delivery was granted a patent in Europe. The film is known as a foamed film, whereby gas is blown into a layer to create a honeycomb structure. The spaces in the structure can be empty, gas filled, stuffed with materials that taste nice or active drugs for delivery. The machines for creating the film have been completed and the company says they will be useful for higher doses of drugs that cannot be contained in single-square melt in the mouth films.

Janus - 18 Sep 2004 13:07 - 925 of 2372

From ftsefrankey on III Christows have this week put a 3.60 price target on BPRG in the next year!

Mmmm I was looking for 10 myself :-)

hlyeo98 - 20 Sep 2004 19:24 - 926 of 2372

In that case I will buy more

hlyeo98 - 24 Sep 2004 17:44 - 927 of 2372

Interims will be out on 29/9/2004 - I bought more today as the interim is most likely to be favourable. We think alike, Janus!

hlyeo98 - 24 Sep 2004 17:45 - 928 of 2372

1.18 today

jays - 27 Sep 2004 14:16 - 929 of 2372

Janus, excuse the ignorance but who are Christows?

AdieH - 27 Sep 2004 14:21 - 930 of 2372

Broker just appointed by BPRG, like their calculations.

emailpat - 27 Sep 2004 14:27 - 931 of 2372

sorry wrong thread.

Janus - 28 Sep 2004 20:04 - 932 of 2372

I'm led to believe the court result will be out on Friday, should be an interesting day if true.

emailpat - 29 Sep 2004 07:32 - 933 of 2372

Janus-well done -confirmed by bprg

azhar - 29 Sep 2004 08:17 - 934 of 2372

Bioprogress to make 'significant' announcements in near future
AFX


LONDON (AFX) - BioProgress PLC said that it expects to make further significant announcements in the next few months, as the group, which makes soluble edible films for the pharmaceutical market, announced results for the first half to June 30 2004.

First half sales were 992,000 stg, while pretax losses came in at 3.8 mln stg, after administrative expenses of 4.4 mln stg -- which included a number of exceptionally high legal, consultancy and other items that are not expected to reoccur.

The results are effectively the first full interim results as the previous interims covered only a few weeks from 22 May 2003 to 30 June 2003.

As at 30 June 2004, BioProgress had cash of 13.3 mln stg.

'In the last few months, we have signed exciting new agreements with FMC, Perrigo, Wyeth and Micap. These interim results can only begin to reveal the potential behind these agreements, as well as our work with customers like Colgate Palmolive,' commented Graham Hind, Chief Executive.

'We have a very strong balance sheet and we expect to be making further significant announcements in the coming months.'

etain.lavelle@afxnews.com

el/

hlyeo98 - 30 Sep 2004 18:15 - 935 of 2372

still a buy at 121.5p

ptholden - 30 Sep 2004 19:02 - 936 of 2372

Definately agree with you on this one Hyleo. Whatever the result of the CC, I feel sure that BPGR will be making a succession of announcements over the coming months, agreements / contracts etc and will be a BUY for the forseeable future.

Regards

PTH

petralva - 01 Oct 2004 07:31 - 937 of 2372

9am it is but which way?

artey - 01 Oct 2004 07:36 - 938 of 2372

one way north, on todays latest news alone.
Register now or login to post to this thread.